BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 24395976)

  • 21. Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells.
    Affolter VK; Moore PF
    Am J Dermatopathol; 2000 Feb; 22(1):40-8. PubMed ID: 10698216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classifying histiocytosis, a heterogeneous group of predominantly cutaneous disorders].
    Wechsler J
    Ann Dermatol Venereol; 2013 Feb; 140(2):79-82. PubMed ID: 23395487
    [No Abstract]   [Full Text] [Related]  

  • 23. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders.
    Moore PF
    Vet Pathol; 1986 Nov; 23(6):757-62. PubMed ID: 3027941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous histiocytic proliferations.
    van der Valk P; Meijer CJ
    Dermatol Clin; 1985 Oct; 3(4):705-17. PubMed ID: 3916176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Langerhans cell histiocytosis in cats and a literature review of feline histiocytic diseases.
    Argenta FF; de Britto FC; Pereira PR; Rissi DR; Gomes C; da Costa FVA; Pavarini SP
    J Feline Med Surg; 2020 Apr; 22(4):305-312. PubMed ID: 30977699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antemortem cytologic diagnosis of pulmonary Langerhans cell histiocytosis in a cat.
    Mau A; Chiu ES; Armien A; Johnson LR; Moore PF; Vernau W
    Vet Clin Pathol; 2023 Dec; 52(4):691-697. PubMed ID: 37914537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant histiocytosis in a cat.
    Court EA; Earnest-Koons KA; Barr SC; Gould WJ
    J Am Vet Med Assoc; 1993 Nov; 203(9):1300-2. PubMed ID: 8253623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canine histiocytic neoplasia: an overview.
    Fulmer AK; Mauldin GE
    Can Vet J; 2007 Oct; 48(10):1041-3, 1046-50. PubMed ID: 17987966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical presentation and histopathologic-immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever.
    Constantino-Casas F; Mayhew D; Hoather TM; Dobson JM
    Vet Pathol; 2011 May; 48(3):764-71. PubMed ID: 20930108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary malignant histiocytosis of the brain in a dog.
    Chandra AM; Ginn PE
    J Comp Pathol; 1999 Jul; 121(1):77-82. PubMed ID: 10373296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma.
    Kato Y; Murakami M; Hoshino Y; Mori T; Maruo K; Hirata A; Nakagawa TL; Yanai T; Sakai H
    J Comp Pathol; 2013 Feb; 148(2-3):188-96. PubMed ID: 22901707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feline progressive histiocytosis: a retrospective investigation of 26 cases and preliminary study of Ki67 as a prognostic marker.
    Coste M; Prata D; Castiglioni V; Minoli L; Etienne-Raffestin CL; Boulouha L; Moreau S; Lagadic M
    J Vet Diagn Invest; 2019 Nov; 31(6):801-808. PubMed ID: 31650906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
    Lau SK; Chu PG; Weiss LM
    Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant histiocytosis in a Bernese mountain dog presenting as a mandibular mass.
    Carioto L
    Can Vet J; 1997 Feb; 38(2):105-7. PubMed ID: 9028594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis.
    Audouin J; Vercelli-Retta J; Le Tourneau A; Adida C; Camilleri-Broët S; Molina T; Diebold J
    Pathol Res Pract; 2003; 199(2):107-12. PubMed ID: 12747473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenic myeloid metaplasia, histiocytosis, and hypersplenism in the dog (65 cases).
    Spangler WL; Kass PH
    Vet Pathol; 1999 Nov; 36(6):583-93. PubMed ID: 10568439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant histiocytosis in four dogs.
    Wellman ML; Davenport DJ; Morton D; Jacobs RM
    J Am Vet Med Assoc; 1985 Nov; 187(9):919-21. PubMed ID: 4055515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of cell line and in vivo mouse model of canine Langerhans cell histiocytosis.
    Son NV; Uchida K; Thongtharb A; Chambers JK; Kishimoto TE; Tomiyasu H; Ohmi A; Tsujimoto H; Nakayama H
    Vet Comp Oncol; 2019 Sep; 17(3):345-353. PubMed ID: 30884050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.
    Favara BE; Feller AC; Pauli M; Jaffe ES; Weiss LM; Arico M; Bucsky P; Egeler RM; Elinder G; Gadner H; Gresik M; Henter JI; Imashuku S; Janka-Schaub G; Jaffe R; Ladisch S; Nezelof C; Pritchard J
    Med Pediatr Oncol; 1997 Sep; 29(3):157-66. PubMed ID: 9212839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.